外科创伤在癌症患者可以导致免疫抑制:最新进展和可能的治疗选择|CTM
2020年4月29日,Clinical and Translational Medicine期刊在线发表了四川大学Xiawei Wei教授团队的综述 “ Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies”[6]( 点击文末 “阅读原文” 下载PDF全文 )。
参考文献:
1. Pan H,Gray R, Braybrooke J, et al. 20-year risks of breast-cancer recurrence afterstopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836-1846.2. ShapiroJ, van Lanschot JJB, Hulshof M, et al. Neoadjuvant chemoradiotherapy plussurgery versus surgery alone for oesophageal or junctional cancer (CROSS):long-term results of a randomised controlled trial. Lancet Oncol.2015;16(9):1090-1098.3. MahviDA, Liu R, GrinstaffMW, Colson YL, Raut CP. Local cancer recurrence: therealities, challenges, and opportunities for new therapies. CA Cancer J Clin.2018;68(6):488-505.4. AlievaM, van Rheenen J, Broekman MLD. Potential impact of invasive surgicalprocedures on primary tumor growth and metastasis. Clin Exp Metastasis.2018;35(4):319-331.5. Tohme S,Simmons RL, Tsung A. Surgery for cancer: a trigger for metastases. Cancer Res.2017;77(7):1548-1552.6. Tang F,Tie Y, Tu C, Wei X. Surgical trauma-induced immunosuppression in cancer: Recentadvances and the potential therapies. Clin Transl Med . 2020;10:199–223.
关于期刊
CTM刊登临床和转化医学方面的文章,旨在促进临床前研究向临床应用的转化,加强基础和临床科学家之间的交流。本期刊聚焦新生物技术、生物材料、生物工程、疾病特异性生物标记物、细胞和分子医学、组学科学、生物信息学、应用免疫学、分子成像、药物发现和开发以及监管和卫生政策。CTM竭诚欢迎临床医生、研究人员、决策者和业界人士免费阅读期刊内容并积极向期刊投稿!
排版|Melody